التداخل بين ميتابيفات وأوميبرازول وبيكربونات الصوديوم

Table 6: Clinically Relevant Interactions Affecting Omeprazole when Co-Administered with Other Drugs CYP2C19 or CYP3A4 Inducers Clinical Impact: Decreased exposure of omeprazole when used concomitantly with strong inducers [see Clinical Pharmacology ( 12.3 )] .

John’s Wort or Rifampin Drugs which induce CYP2C19 or CYP3A4 (such as St.